300 related articles for article (PubMed ID: 34208103)
21. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D
Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382
[TBL] [Abstract][Full Text] [Related]
23. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with
Hibi A; Mizuguchi K; Yoneyama A; Kasugai T; Kamiya K; Kamiya K; Ito C; Kominato S; Miura T; Koyama K
Ren Replace Ther; 2018; 4(1):16. PubMed ID: 34171004
[TBL] [Abstract][Full Text] [Related]
24. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
25. Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls.
Sato H; Kanno A; Sato M; Endo A; Ito H; Ohara T; Shirota Y; Sumitomo K; Mori T; Furukawa K
Front Immunol; 2023; 14():1266187. PubMed ID: 37901232
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
[TBL] [Abstract][Full Text] [Related]
27. [Thrombotic microangiopathy developing subsequent to tocilizumab therapy in a patient with TAFRO syndrome].
Ito S; Tsutsumi Y; Kikuchi R; Matsuoka S; Shimoyama N
Rinsho Ketsueki; 2018; 59(11):2432-2437. PubMed ID: 30531139
[TBL] [Abstract][Full Text] [Related]
28. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.
Furuto Y; Hashimoto H; Horiuti H; Shibuya Y
Medicine (Baltimore); 2018 Jun; 97(24):e11057. PubMed ID: 29901607
[TBL] [Abstract][Full Text] [Related]
29. Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.
Noda Y; Saka Y; Kato A; Mimura T; Naruse T
Clin Nephrol Case Stud; 2018; 6():16-20. PubMed ID: 30009125
[TBL] [Abstract][Full Text] [Related]
30. TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review.
Grange L; Chalayer E; Boutboul D; Paul S; Galicier L; Gramont B; Killian M
Autoimmun Rev; 2022 Aug; 21(8):103137. PubMed ID: 35803499
[TBL] [Abstract][Full Text] [Related]
31. Case report and literature review: Glomerular and neurologic thrombotic microangiopathy as a primary manifestation of multicentric castleman disease.
Flahault A; Vignon M; Rabant M; Hummel A; Noël LH; Canioni D; Knebelmann B; Suarez F; El Karoui K
Medicine (Baltimore); 2016 Oct; 95(41):e5047. PubMed ID: 27741115
[TBL] [Abstract][Full Text] [Related]
32. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
[TBL] [Abstract][Full Text] [Related]
33. TAFRO syndrome: A disease that known is half cured.
Chen T; Feng C; Zhang X; Zhou J
Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
[TBL] [Abstract][Full Text] [Related]
34. Renal failure in pediatric Castleman disease: Four French cases with thrombotic microangiopathy.
Cousin E; Flodrops H; Boyer O; Hogan J; Ruin M; Couderc A; Goujon JM; Taque S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27045. PubMed ID: 29603588
[TBL] [Abstract][Full Text] [Related]
35. International definition of iMCD-TAFRO: future perspectives.
Nishimura Y; Nishimura MF; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):73-78. PubMed ID: 35474036
[TBL] [Abstract][Full Text] [Related]
36. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.
Iwaki N; Gion Y; Kondo E; Kawano M; Masunari T; Moro H; Nikkuni K; Takai K; Hagihara M; Hashimoto Y; Yokota K; Okamoto M; Nakao S; Yoshino T; Sato Y
Sci Rep; 2017 Feb; 7():42316. PubMed ID: 28205564
[TBL] [Abstract][Full Text] [Related]
38. TAFRO syndrome: 2 cases and review of the literature.
Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
[TBL] [Abstract][Full Text] [Related]
39. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
Takai K
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266
[TBL] [Abstract][Full Text] [Related]
40. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
